skip to Main Content

Findorff's Response to the Coronavirus (COVID-19)

‘Unprecedented’ Pace Of COVID-19 Drug Development Pushing Madison Companies To Expand

‘Unprecedented’ pace of COVID-19 drug development pushing Madison companies to expand

Spurred on by the push to end the COVID-19 pandemic, Catalent Biologics is rapidly expanding its Madison facilities and staff to account for increased production of substances used by various pharmaceutical companies around the world.

Joint Our Email List
  • Join Our Email List

  • Subscribe to Updates

Back To Top